Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Methyl
100%
Human Brain
100%
5-HT2 Receptor
100%
Serotonin
100%
Positron Emission Tomography/computed Tomography (PET/CT)
100%
Frontal Cortex
33%
Cerebellum
33%
Brain Regions
16%
Caudate
16%
Clinical Trials
16%
Putamen
16%
Receptor Antagonist
16%
Normal Human
16%
Receptor Density
16%
Low Affinity
16%
Imaging Agents
16%
Radioligand
16%
Activity Level
16%
Intravenous Injection
16%
Serotonergic
16%
Radioactivity
16%
Human Volunteers
16%
Cortical Regions
16%
Non-specific Binding
16%
Temporal Cortex
16%
Parietal Cortex
16%
Older Volunteers
16%
Regional Distribution
16%
Dopamine D2 Receptor (DRD2)
16%
Selective Labeling
16%
Baboon
16%
Non-radioactive
16%
Receptor Binding Assay
16%
Ketanserin
16%
Secondary Interactions
16%
Positron Emission Tomography Imaging
16%
Neuroscience
Positron Emission Tomography
100%
Serotonin
100%
Receptor
100%
Human Brain
100%
Frontal Lobe
33%
Cerebellum
33%
Putamen
16%
In Vivo
16%
In Vitro
16%
Serotonergic
16%
Receptor Antagonist
16%
Radioligand
16%
Temporal Lobe
16%
Receptor Binding
16%
Dopamine Receptor D2
16%
Parietal Cortex
16%
Ketanserin
16%
Brain Region
16%
Cortical Region
16%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Carbon 11
100%
Serotonin
100%
Clinical Trial
16%
Normal Human
16%
Serotonin 2 Antagonist
16%
Tracer
16%
Radioligand
16%
Dopamine Receptor D2
16%
Ligand Binding Assay
16%
Ketanserin
16%